Circulating pEGFR Is a Candidate Response Biomarker of Cetuximab Therapy in Colorectal Cancer

Θεοδώρα Κάτσιλα(Universitat Autònoma de Barcelona), Josep Villanueva(Universitat Autònoma de Barcelona)

Clinical Cancer Research

October 17, 2014

10.1158/1078-0432.ccr-14-0361

Cited by 25

Related Papers

Differential exoprotease activities confer tumor-specific serum peptidome patterns

|Journal of Clinical Investigation|2005|748